These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34176610)

  • 61. Assessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes and Personal Treatment (ADAPT) Survey in Teens and Young Adults.
    Commissariat PV; Volkening LK; Weinzimer SA; Dassau E; Laffel LM
    Can J Diabetes; 2023 Feb; 47(1):66-72. PubMed ID: 36184368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Twelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes.
    Commissariat PV; DiMeglio LA; Kanapka LG; Laffel LM; Miller KM; Anderson BJ; Hilliard ME;
    Diabet Med; 2023 Aug; 40(8):e15120. PubMed ID: 37083018
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL).
    Kataoka Y; Hosoda K; Makino H; Matsubara M; Matsuo M; Ohata Y; Koezuka R; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Son C; Nishimura K; Asaumi Y; Miyamoto Y; Noguchi T; Yasuda S
    Cardiovasc Diagn Ther; 2019 Oct; 9(5):431-438. PubMed ID: 31737515
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review.
    Taylor PJ; Thompson CH; Brinkworth GD
    J Diabetes Investig; 2018 Jul; 9(4):713-725. PubMed ID: 29380542
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis.
    Hood KK; Peterson CM; Rohan JM; Drotar D
    Pediatrics; 2009 Dec; 124(6):e1171-9. PubMed ID: 19884476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relation of Health-Related Quality of Life with Glycemic Control and Use of Diabetes Technology in Children and Adolescents with Type 1 Diabetes: Results from a National Population Based Study.
    Bratke H; Biringer E; Margeirsdottir HD; Njølstad PR; Skrivarhaug T
    J Diabetes Res; 2022; 2022():8401328. PubMed ID: 36387938
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recruitment Into a Pediatric Continuous Glucose Monitoring RCT.
    Volkening LK; Gaffney KC; Katz ML; Laffel LM
    J Diabetes Sci Technol; 2017 Jan; 11(1):100-107. PubMed ID: 27340247
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.
    Steck AK; Dong F; Geno Rasmussen C; Bautista K; Sepulveda F; Baxter J; Yu L; Frohnert BI; Rewers MJ;
    Diabetes Care; 2022 Feb; 45(2):365-371. PubMed ID: 34880069
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change.
    Hood KK; Rausch JR; Dolan LM
    Pediatr Diabetes; 2011 Dec; 12(8):718-23. PubMed ID: 21564454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based, Randomized, Controlled Trial.
    Sherifali D; Brozic A; Agema P; Punthakee Z; McInnes N; O'Reilly D; Usman Ali RM; Ibrahim S; Gerstein HC
    Can J Diabetes; 2021 Oct; 45(7):594-600. PubMed ID: 33582039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of continuous glucose monitoring on everyday life of young children with type 1 diabetes and their parents: An evaluation of 114 families.
    Aouchiche K; Bernoux D; Baechler Sadoul E; Haine E; Joubert F; Epstein S; Faure Galon N; Dalla-Vale F; Combe JC; Samper M; Simonin G; Castets S; Marquant E; Vergier J; Reynaud R
    Prim Care Diabetes; 2024 Feb; 18(1):91-96. PubMed ID: 38000979
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adherence to glycemic monitoring in diabetes.
    Patton SR
    J Diabetes Sci Technol; 2015 May; 9(3):668-75. PubMed ID: 25591853
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessing Glycemic Control Using CGM for Women with Diabetes in Pregnancy.
    O'Malley G; Wang A; Ogyaadu S; Levy CJ
    Curr Diab Rep; 2021 Nov; 21(11):44. PubMed ID: 34735626
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intermittent Use of Continuous Glucose Monitoring: A New Paradigm in Treatment of Type 2 Diabetes.
    Saboo B; Unnikrishnan R; Kesavadev J; Tiwaskar M; Czupryniak L; Chawla M; Choudhary P; Battelino T; Agarwal S; Danne T; Mohan V
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355844
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Do the effects of psychological treatments on improving glycemic control in type 1 diabetes persist over time? A long-term follow-up of a randomized controlled trial.
    Ridge K; Bartlett J; Cheah Y; Thomas S; Lawrence-Smith G; Winkley K; Ismail K
    Psychosom Med; 2012 Apr; 74(3):319-23. PubMed ID: 22434919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
    Irace C; Cutruzzolà A; Tweden K; Kaufman FR
    Expert Rev Med Devices; 2021 Oct; 18(10):909-914. PubMed ID: 34528851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Virtual reality's impact on children with type 1 diabetes: a proof-of-concept randomized cross-over trial on anxiety, pain, adherence, and glycemic control.
    Gruber N; Shemesh-Iron M; Kraft E; Mitelberg K; Mauda E; Ben-Ami M; Mazor-Aronovitch K; Levy-Shraga Y; Levran N; Levek N; Zimlichman E; Pinhas-Hamiel O
    Acta Diabetol; 2024 Feb; 61(2):215-224. PubMed ID: 37845502
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 'Much more convenient, just as effective': Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.
    Tanenbaum ML; Zaharieva DP; Addala A; Prahalad P; Hooper JA; Leverenz B; Cortes AL; Arrizon-Ruiz N; Pang E; Bishop F; Maahs DM
    Diabet Med; 2022 Nov; 39(11):e14923. PubMed ID: 35899591
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 Diabetes.
    Polonsky WH; Fortmann AL
    J Diabetes Sci Technol; 2022 Jan; 16(1):97-105. PubMed ID: 33322931
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings.
    Erie C; Van Name MA; Weyman K; Weinzimer SA; Finnegan J; Sikes K; Tamborlane WV; Sherr JL
    Pediatr Diabetes; 2018 Feb; 19(1):92-97. PubMed ID: 28303678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.